Brain Stimulation Therapies Show Promise for Adult ADHD but Need Larger Trials
A meta-analysis comparing neurofeedback, tDCS, and TMS for adult ADHD finds encouraging signals but no technique yet reaches statistical significance.
Summary
A systematic review and meta-analysis from GHU Paris examined three non-pharmacological brain-based therapies for adult ADHD: neurofeedback, transcranial direct current stimulation (tDCS), and repetitive transcranial magnetic stimulation (rTMS). Researchers screened 1,747 articles, selecting 18 for detailed analysis. tDCS and rTMS demonstrated the strongest methodological designs. Specific protocols showed promise — tDCS with anode at F3 and cathode at F4 at 2 mA, and rTMS targeting the dorsolateral prefrontal cortex at high frequency using a deep coil. However, meta-analysis results did not reach statistical significance for any technique. Medication showed minimal impact in reviewed studies. Neurofeedback, while lacking strong study quality, remains a viable option for patients reluctant to try neuromodulation. Larger trials and combination approaches are needed.
Detailed Summary
Adult ADHD remains underserved therapeutically. While stimulant medications are effective, many adults seek alternatives due to side effects, stigma, or comorbidities. Non-invasive neuromodulation techniques — including neurofeedback, tDCS, and rTMS — have emerged as candidate therapies, but their efficacy in adults specifically has lacked rigorous comparative evaluation.
Researchers at GHU Paris conducted a systematic review and meta-analysis across five major databases, screening 1,747 articles and ultimately analyzing 18 studies meeting inclusion criteria. The review compared all three modalities on both methodological quality and clinical outcomes for ADHD symptoms in adults.
tDCS and rTMS emerged with the most methodologically robust study designs. tDCS appeared most effective when applied with the anode at F3 and cathode at F4 at 2 mA — a protocol targeting left prefrontal cortex excitability. rTMS showed the strongest effects when applied unilaterally to the dorsolateral prefrontal cortex (DLPFC) at high frequency, with deep coil configurations outperforming standard ones. Notably, concurrent medication use had little to no measurable effect on outcomes across the reviewed studies, suggesting these therapies may operate through independent mechanisms.
Despite these directional findings, the meta-analysis did not achieve statistical significance for any of the three techniques. This reflects the field's broader challenge: small sample sizes, heterogeneous protocols, and limited replication. Neurofeedback studies were especially limited in methodological quality, though the technique may still serve patients who are unwilling or unable to undergo device-based neuromodulation.
The authors advocate for larger, well-powered trials — particularly for tDCS and TMS — and suggest that combining tDCS with cognitive training or other therapies could amplify therapeutic gains. Investigating how psychiatric comorbidities affect treatment response is also flagged as a priority for future work.
Key Findings
- tDCS at F3 anode / F4 cathode at 2 mA showed the most consistent efficacy signal among reviewed protocols.
- High-frequency rTMS targeting the DLPFC with a deep coil produced the strongest TMS outcomes.
- Meta-analysis did not reach statistical significance for neurofeedback, tDCS, or rTMS.
- Concurrent medication had little to no detectable effect on outcomes across included studies.
- Neurofeedback remains a viable option for patients reluctant to undergo device-based neuromodulation.
Methodology
Systematic review and meta-analysis across PubMed, Web of Science, Cochrane Library, Ovid, and ScienceDirect. From 1,747 identified articles, 18 met inclusion criteria for detailed analysis comparing neurofeedback, tDCS, and rTMS in adult ADHD populations. Methodological quality and clinical outcomes were assessed across modalities.
Study Limitations
The meta-analysis failed to reach statistical significance for any technique, limiting definitive clinical conclusions. Sample sizes across included studies were small and protocols were heterogeneous, reducing comparability. The first author disclosed active training as a neurofeedback therapist and neuromodulation operator, representing a potential conflict of interest.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
